WallStreetZenWallStreetZen

NASDAQ: MIST
Milestone Pharmaceuticals Inc Stock Ownership - Who owns Milestone Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Milestone Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph OlivetoPresident and CEO2026-04-1636,500$2.26
$82.49kSell
Jeffrey Edward NelsonChief Operating Officer2026-01-2612,245$1.93
$23.63kSell
Amit HasijaCFO EVP of Corp. Development2026-01-2612,245$1.93
$23.63kSell
David BharuchaChief Medical Officer2026-01-2612,245$1.93
$23.63kSell
Joseph OlivetoPresident and CEO2026-01-2634,523$1.93
$66.63kSell
Lorenz MullerChief Commercial Officer2026-01-2611,180$1.93
$21.58kSell
Joseph OlivetoPresident and CEO2026-01-0843,000$2.25
$96.75kSell
Joseph OlivetoPresident and CEO2026-01-07500$2.25
$1.13kSell
Jeffrey Edward NelsonChief Operating Officer2025-12-1558,007$2.32
$134.58kSell
Amit HasijaCFO EVP of Corp. Development2025-12-1558,007$2.32
$134.58kSell

1 of 2

MIST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIST insiders and whales buy or sell their stock.

MIST Shareholders

What type of owners hold Milestone Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP6.08%7,571,204$9.92MInsider
Rtw Investments LP5.09%6,331,001$8.29MInstitution
Propel Bio Management LLC3.31%4,118,321$5.40MInstitution
Holdings A. Novo1.96%2,434,470$3.19MInsider
Two Sigma Investments LP1.86%2,317,176$3.04MInstitution
De Solidarite Des Travailleurs Du Quebec Fonds1.81%2,254,920$2.95MInsider
Goldman Sachs Group Inc 11.61%2,000,025$2.62MInstitution
Marshall Wace LLP1.56%1,944,530$2.55MInstitution
Millennium Management LLC1.24%1,544,325$2.02MInstitution
Simplify Asset Management Inc1.21%1,506,405$1.97MInstitution

1 of 3

MIST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIST23.93%10.86%Net SellingNet Selling
CRBU38.16%8.68%Net Selling
TNYA25.03%38.16%Net SellingNet Selling
NGEN2.08%0.00%
CRBP46.35%53.65%Net SellingNet Buying
View Top Biotech Stocks

Milestone Pharmaceuticals Stock Ownership FAQ

Who owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals (NASDAQ: MIST) is owned by 23.93% institutional shareholders, 10.86% Milestone Pharmaceuticals insiders, and 65.20% retail investors. Rtw Investments LP is the largest individual Milestone Pharmaceuticals shareholder, owning 7.57M shares representing 6.08% of the company. Rtw Investments LP's Milestone Pharmaceuticals shares are currently valued at $9.84M.

If you're new to stock investing, here's how to buy Milestone Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.